Yuko Matsunaga

2.5k citations
51 papers · 1.9k indexed · 2 hit papers · h-index 19
Topics
Antibiotics Pharmacokinetics and Efficacy (11 papers)Asthma and respiratory diseases (11 papers)Antibiotic Resistance in Bacteria (9 papers)
Partner nations
JapanUnited StatesGreece

In The Last Decade

Yuko Matsunaga

51 papers receiving 1.9k citations

Hit Papers

Efficacy and safety of cefiderocol or best available ther...202020262022202420202020100200300400500

Peers

Yuko Matsunaga
Comparison fields: 5 of 101
  • Molecular Medicine 853
  • Pharmacology 651
  • Applied Microbiology and Biotechnology 394
  • Immunology 390
  • Epidemiology 346
Replace Josiane Pierre with:
Josiane Pierre France
Guido Granata Italy
Philipp M. Lepper Germany
Giorgia Montrucchio Italy
Canmao Xie China
Judith Branger Netherlands
Nicholas M. Smith United States
Lili Tao China
Kunihiko Kooguchi Japan
Ganzhu Feng China
Yuko Matsunaga relative to Josiane Pierre France Josiane Pierre's profile →
Citations per field
00.5×10×13.6×
Josiane Pierre · 1×
Citations per year

Countries citing papers authored by Yuko Matsunaga

Since Specialization
Citations

This map shows the geographic impact of Yuko Matsunaga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuko Matsunaga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuko Matsunaga more than expected).

Fields of papers citing papers by Yuko Matsunaga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuko Matsunaga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuko Matsunaga. The network helps show where Yuko Matsunaga may publish in the future.

Co-authorship network of co-authors of Yuko Matsunaga

This figure shows the co-authorship network connecting the top 25 collaborators of Yuko Matsunaga. A scholar is included among the top collaborators of Yuko Matsunaga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuko Matsunaga. Yuko Matsunaga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 53
2 5
3 29
4 8
5 2
6
Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trialbreakdown →
319
7 27
8 5
9 28
10 12
11 8
12 16
13 166
14 11
15 31
16 39
17 102
18 21
19 6
20 31

About Yuko Matsunaga

Yuko Matsunaga is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Pharmacology, having authored 51 papers that have together received 1.9k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (11 papers), Asthma and respiratory diseases (11 papers) and Antibiotic Resistance in Bacteria (9 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (394 citations), Molecular Medicine (853 citations) and Pharmacology (651 citations). Yuko Matsunaga has collaborated with scholars based in Japan, United States and Greece. Frequent co-authors include Roger Echols, Tsutae Den Nagata, Mari Ariyasu, Richard G. Wunderink, Yohei Doi, Simon Portsmouth, Matteo Bassetti, Kiichiro Toyoizumi, Hiromasa Inoue and Thomas P. Lodise. Their work appears in journals such as Nature Immunology, The Journal of Immunology and Oncogene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026